In short
The 2025 emergency vertigo guideline teaches rapid distinction of peripheral (BPPV, vestibular neuritis, Meniere) from dangerous central causes (stroke, cerebellar hemorrhage) using HINTS, with targeted repositioning, steroids, or urgent stroke thrombolysis.
What this guide covers: Peripheral vs central vertigo · Bedside assessment · Targeted treatment · Special groups · For patients
Peripheral vs central vertigo
About half of ER vertigo is peripheral (inner-ear/vestibular); 15–25% is central (brainstem/cerebellum) and potentially dangerous. Rapid triage is the guideline's core message.
Bedside assessment
The HINTS exam (head-impulse, nystagmus type, skew/deviated gaze) helps separate stroke from benign causes. Duration, triggers, hearing change, and neurologic signs refine the diagnosis.
Targeted treatment
BPPV is treated with canalith repositioning (Epley/Barbecue). Vestibular neuritis gets steroids and vestibular suppressants short-term. Central stroke within window may need thrombolysis; cerebellar hemorrhage may need surgery.
Special groups
Older adults avoid prolonged vestibular suppressants (fall risk); pregnant patients use manual repositioning; children need infection exclusion.
For patients
Sudden severe vertigo with headache, double vision, limb weakness, or trouble speaking is a stroke warning—call emergency services immediately.
Sources and further reading
One reference to a U.S. government health source (National Institutes of Health or MedlinePlus) for the medical background of this guide. It is context, not a substitute for advice from your treating doctor.
General information for international patients, not medical advice or a diagnosis. Read the medical disclaimer.





